Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Renal Function Is Preserved after Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Emily Limerick, MD, Neal Jeffries, PhD, Clarissa Diamantidis, MD, Yuliya Lokhnygina, PhD, Matthew M. Hsieh, MD, Courtney D. Fitzhugh, MD

Blood (2020) 136 (Supplement 1): 58–59.

https://doi.org/10.1182/blood-2020-142630

Published: 2020

Journal Articles

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Adetola A. Kassim, MDMS, Josu de la Fuente, Ali Debsan Alahmari, MBBS, MD MNAMS, Michael J. Eckrich, MD MPH, Rabi Hanna, MD, Nathalie Dhedin, MD, Biljana N. Horn, MD, Vandy Black, MDMSc, Roseane V Gouveia, Adriana Seber, MDMS, Belinda Pinto Simões, MD PhD, Thalita Cristina de Mello Costa, MD, Renato Guerino-Cunha, Carmem M. S. Bonfim, MDPhD, Roberto Luiz da Silva, Nelson Hamerschlak, MD PhD, Juliana Folloni Fernandes, MD, Michael Kent, MDBS, Satya Prakash Yadav, MBBS, MD, Erfan Nur, MDPhD, Mohsen Alzahrani, Ben Carpenter, PhD, William Tse, MD, Maria Isabel, Hemalatha G Rangarajan, MD, Ibrahim Ahmed, MD, Adeseye Michael Akinsete, MBBS, Courtney D. Fitzhugh, MD, Kathryn A. Culos, PharmD, Leena Karnik, FRCPath, MRCP, James Connelly, MD, Carrie Kitko, MD, Jennifer Andrews, MDMSc, Karina L Wilkerson, NP, MSN, Robert Brodsky, Tatsuki Koyama, Michael R. DeBaun, MD MPH

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-141771

Published: 2020

Journal Articles

Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal Study

Omar Niss, MD, Adam Lane, PhD, Monika Asnani, PhD, Marianne McPherson Yee, MD MSc, Ashok Raj, Susan E Creary, MD, Courtney D. Fitzhugh, MD, Prasad V. Bodas, MD, Santosh L. Saraf, MD, Sharada Sarnaik, MD, Charles T. Quinn, MD, Prasad Devarajan, MD, Punam Malik, MD

Blood (2019) 134 (Supplement_1): 1004.

https://doi.org/10.1182/blood-2019-125860

Published: 2019

Journal Articles

Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor

Alexis Leonard, MD, Naoya Uchida, MD, David F. Stroncek, MD, Sandhya R. Panch, MDMPH, Kamille West, Eoghan George Molloy, MD, Tom Hughes, Pharm.D., Sara Hauffe, RN, Tiffani Taylor, Courtney D. Fitzhugh, MD, Jane S. Hankins, MD MS, Megan Wilson, MSW, CCRP, Akshay Sharma, MBBS, Shengdar Q. Tsai, PhD, Mitchell J. Weiss, MD, PhD, Matthew Hsieh, MD, John F. Tisdale, MD

Blood (2019) 134 (Supplement_1): 1964.

https://doi.org/10.1182/blood-2019-126091

Published: 2019

Journal Articles

Characterization of Immune Cells Producing Regulatory Cytokines That Mediate Engraftment in Sickle Cell Disease Patients after Haploidentical Peripheral Blood Stem Cell Transplantation

Berline Francis, Arunakumar Gangaplara, PhD, Deepali K Bhat, PhD, J. Philip McCoy, PhD, Courtney D. Fitzhugh, MD

Blood (2019) 134 (Supplement_1): 803.

https://doi.org/10.1182/blood-2019-130711

Published: 2019

Journal Articles

Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease Who Underwent Haploidentical HSCT

Ahmad Shaikh, Purevdorj Olkhanud, MD PhD, Marjan Gucek, PhD, Sajni Patel, MS, Courtney D. Fitzhugh, MD

Blood (2018) 132 (Supplement 1): 201.

https://doi.org/10.1182/blood-2018-99-118654

Published: 2018

Journal Articles

Pain and Opioid Use after Reversal of Sickle Cell Disease Following Hematopoietic Stem Cell Transplant

Deepika S. Darbari, MD, Jaquette Liljencrantz, MD, Austin Ikechi, Staci Martin, PhD, Roderick Marie Claire, Courtney D. Fitzhugh, MD, John F Tisdale, MD, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Matthew Hsieh, MD

Blood (2017) 130 (Supplement 1): 970.

https://doi.org/10.1182/blood.V130.Suppl_1.970.970

Published: 2017

Journal Articles

Immunohematologic Complications after Nonmyeloablative Hematopoietic Progenitor Cell Transplantation in Patients with Sickle Cell Disease

Elizabeth S. Allen, MD, Matthew M. Hsieh, MD, Courtney D. Fitzhugh, MD, Harvey G. Klein, MD, John F. Tisdale, MD, Willy A. Flegel

Blood (2016) 128 (22): 3404.

https://doi.org/10.1182/blood.V128.22.3404.3404

Published: 2016

Journal Articles

A Novel Recombinant Eklf-GATA1 Fusion Protein Reduces Sickling of Erythrocytes Cultured from CD34 + Cells with Sickle Cell Disease

Jianqiong Zhu, Kyung Chin, Wulin Aerbajinai, MD PhD, Chutima Kumkhaek, PhD, Hongzhen Li, Matthew M. Hsieh, MD, Courtney D. Fitzhugh, MD, Griffin P. Rodgers, MD

Blood (2016) 128 (22): 3506.

https://doi.org/10.1182/blood.V128.22.3506.3506

Published: 2016

Journal Articles

At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation

Courtney D. Fitzhugh, MD, Matthew M. Hsieh, MD, Stefan Cordes, MD, Tiffani Taylor, PA, Wynona Coles, MPH, Katherine Roskom, RN, John F. Tisdale, MD

Blood (2016) 128 (22): 2483.

https://doi.org/10.1182/blood.V128.22.2483.2483

Published: 2016

Journal Articles

A Multi-Center, Phase-2 Trial of Losartan for the Nephropathy of Sickle Cell Anemia

Charles T. Quinn, MD MS, Santosh L. Saraf, MD, Victor R. Gordeuk, MD, Courtney D. Fitzhugh, MD, Susan E Creary, MD MSc, Prasad Bodas, MD, Alex George, MD, PhD, Ashok Raj, MD, Alecia C. Nero, MD, Catherine Terrell, BS, Lisa McCord, BS, Omar Niss, MD, Rubina Dosani, MS, Michael D. Taylor, MD, Prasad Devarajan, MD, Punam Malik, MD

Blood (2016) 128 (22): 265.

https://doi.org/10.1182/blood.V128.22.265.265

Published: 2016

Journal Articles

Fertility Preservation for Women with Sickle Cell Disease (SCD)

Torie C Plowden, MDMPH, Nicole M Millan, BS, Carter M Owen, MD, Mae W Healy, DO, Nicole K Banks, MD, Matthew Hsieh, MD, Courtney D. Fitzhugh, MD, Jeannine Witmyer, PhD, Doug Peak, BS, TS (ABB), David Frankfurter, MD, Alan H DeCherney, MD, John F Tisdale, MD, Erin F Wolff, MD

Blood (2015) 126 (23): 3408.

https://doi.org/10.1182/blood.V126.23.3408.3408

Published: 2015

Journal Articles

Peripheral Blood As a Source Of Cells For Regenerative Medicine Applications In Sickle Cell Disease

Atsushi Fujita, MD, PhD, Courtney D. Fitzhugh, MD, Matthew M. Hsieh, MD, John F. Tisdale, MD, Naoya Uchida, MD, PhD

Blood (2013) 122 (21): 2209.

https://doi.org/10.1182/blood.V122.21.2209.2209

Published: 2013

Journal Articles

Characterization of Early Lymphocytes Emerging After Nonmyeloablative Conditioning and Hematopoietic Stem Cell Transplant Supported with Sirolimus

R. Patrick Weitzel, PhD, Angelique Biancotto, PhD, Courtney D. Fitzhugh, MD, J. Philip McCoy, PhD, Matthew Hsieh, MD, John F. Tisdale, MD

Blood (2012) 120 (21): 4150.

https://doi.org/10.1182/blood.V120.21.4150.4150

Published: 2012

Journal Articles

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Matthew M Hsieh, Courtney D Fitzhugh, MD, R. Patrick Weitzel, PhD, Wynona Coles, M Beth Link, John F. Tisdale

Blood (2011) 118 (21): 10.

https://doi.org/10.1182/blood.V118.21.10.10

Published: 2011

NARROW

Renal Function Is Preserved after Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a Phase II Trial: Vanderbilt Global Haploidentical Transplant Learning Collaborative (VGC 2 )

Progression of Albuminuria in Sickle Cell Anemia: A Multicenter, Longitudinal Study

Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor

Characterization of Immune Cells Producing Regulatory Cytokines That Mediate Engraftment in Sickle Cell Disease Patients after Haploidentical Peripheral Blood Stem Cell Transplantation

Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease Who Underwent Haploidentical HSCT

Pain and Opioid Use after Reversal of Sickle Cell Disease Following Hematopoietic Stem Cell Transplant

Immunohematologic Complications after Nonmyeloablative Hematopoietic Progenitor Cell Transplantation in Patients with Sickle Cell Disease

A Novel Recombinant Eklf-GATA1 Fusion Protein Reduces Sickling of Erythrocytes Cultured from CD34 + Cells with Sickle Cell Disease

At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation

A Multi-Center, Phase-2 Trial of Losartan for the Nephropathy of Sickle Cell Anemia

Fertility Preservation for Women with Sickle Cell Disease (SCD)

Peripheral Blood As a Source Of Cells For Regenerative Medicine Applications In Sickle Cell Disease

Characterization of Early Lymphocytes Emerging After Nonmyeloablative Conditioning and Hematopoietic Stem Cell Transplant Supported with Sirolimus

Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Patients with Severe Sickle Cell Disease (SCD)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only